Catalyst Pharmaceutical Partners to Announce Top-Line Data From CPP-109 …
Catalyst Pharmaceutical Partners to Announce Top-Line Data From CPP-109 …
Filed under: drug treatment news 2012
Catalyst licensed CPP-109 from Brookhaven National Laboratory for the treatment of cocaine and other addictions, and has been granted "Fast Track" status by the U.S. Food and Drug Administration (FDA) for cocaine addiction. Under the Federal Food, Drug …
Read more on MarketWatch (press release)
Celgene psoriatic arthritis drug effective in trial
Filed under: drug treatment news 2012
The company said that a pilot study of apremilast as a treatment for rheumatoid arthritis, when given in combination with the treatment methotrexate, did not achieve its main goal. Data from a second study testing the drug without methotrexate are …
Read more on Reuters
Immunotherapy in Oncology Drug Pipeline Update 2012
Filed under: drug treatment news 2012
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and …
Read more on MarketWatch (press release)
Hilo shoplifter sentenced to jail and drug treatment
Filed under: drug treatment news 2012
Prosecuting Attorney Charlene Y. lboshi announced today that on July 12, 2012, Third Circuit Court Judge Glenn S. Hara sentenced Hilo resident Gayleen Oda, 35, to five years probation following …
Read more on Hawaii 24/7 (press release)
Catalyst Pharmaceutical Partners To Announce Top-Line Data From CPP-109 Phase II(b) Clinical Trial For The Treatment …
CORAL GABLES, Fla. — Catalyst Pharmaceutical Partners, Inc. today announced that it expects to report top-line results from its CPP-109 (vigabatrin) Phase II(b) trial around the end of September 2012 … Read News